The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Honoraria - Best Doctors, Inc
Consulting or Advisory Role - Best Doctors, Inc
Research Funding - Macrogenics
A phase 1, open-label, dose escalation study of enoblituzumab (MGA271) in pediatric patients with B7-H3-expressing relapsed or refractory solid tumors.
 
Kenneth Desantes
No Relationships to Disclose
 
John M. Maris
Research Funding - GlaxoSmithKline; Novartis
 
Kimberly McDowell
No Relationships to Disclose
 
Crystal Mackall
Research Funding - Bluebird Bio
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
 
Sadhna Shankar
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Jim Vasselli
No Relationships to Disclose
 
Francine Chen
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
Patents, Royalties, Other Intellectual Property - Patent Award/Application: 1. Antibodies Reactive with B7H3 immunological activity fragments thereof and Uses Thereof 2. Bi-Specific Monovalent Diabodies That Are Capable Of Binding to GPA33 And CD3, And Uses Thereof (Inst)
 
Deryk Loo
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
Patents, Royalties, Other Intellectual Property - Author on patents submitted and published as an employee of MacroGenics, Inc. (Inst)
 
Paul A. Moore
Stock and Other Ownership Interests - GlaxoSmithKline; Medtronic; Teva
Patents, Royalties, Other Intellectual Property - Have patents based on work at MacroGenics, Human Genome Sciences and Celera
 
Jon M. Wigginton
Employment - Macrogenics
Leadership - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Paul M. Sondel
No Relationships to Disclose